Epidermolytic hyperkeratosis (bullous congenital ichthyosiform erythroderma) is an autosomal dominant skin disord er caused by defects in the suprabasal keratins. Recently, mutations in the keratins 1 and 10 have been identified in patients with this disease. In this study, direct gene sequencing was used to establish the prenatal diagnosis in 1S-week gestation twins at risk for epidermolytic hyperkeratosis. Direct sequence analysis of genomic DNA from the affected father and from both chorionic villus samples revealed a tyrosine to asparagine mutation at position 14 within the highly con-E pidermol ytic hyperkeratosis (EHK) is an autosomal dominant genodermatosis (number 11380 in McKusick [1 J ) manifested by erythroderma and widespread blistering at birth and the development of hyperkeratosis in later weeks [2J. Blistering is less commo n in older individuals but superficial erosions can occur after phys ical trauma, stress, or in some patients, on treatment with retinoids . Histopathology is charac terized by a marked expansion of the granular and stratum corneum laye rs. Analysis of blistering skin shows cytolysis and intra-epidermal cleavage in the suprabasallayers [3] . The ultrastructural hallmark of EHK is the appearance of keratin filament aggregates and clumping, often with a pe:inuclear distribution , in the spinous and granular cells of these patIents [4, 5] . In fact, ultrastructural studies were the first to suggest an association between the disease and defects in the suprabasal keratins [4 -6J and this view was later reinforced by immunochemical [7] and gene linkage [8 -to] studies. Recently, we and others have described mutations in highly conserved regions of keratins 1 and 10 (K1 and K10) in patients with this di sease [11] [12] [13] [14] . All defects documented in EHK patients to date have involved point mutations resulting in amino acid substitutions within the HI segment of K 1 or within the specialized sequences at the ends of the rod domains of Kl and K10 . These conserved regions are critical to normal filament function and assembly, and mutations in them are tho ught to weaken the integrity of these filaments, leading to collapse of the network and tonofilam ent clumping around the nucleus (reviewed in [15] . Interestingly, most of these mutations occur within a conserved sequence motif at the beginning of the rod domain of Kl 0, with th e arginine codon at position 10 being particularly vulnerable to mutation [14] .
Prenatal diagnosis of EHK has been performed previously by ultrastructural analysis of fetal skin biopsies and on amn.iotic fluid served lA alpha-helical segment of keratin 10. None of the unaffected family members that were analyzed exhibit this mutation nor have polymorphic variations been observed in the normal population at this position. This residue is invariant in all type I keratins sequenced to date and is also conserved in related intermediate fil ament proteins such as vimen tin and lamin. Given this high degree of conservation it is probable that any mutation at this position is deleterious and will result in disease. Key wo rds: keratins/ mutatiol1s/disease/genetics. ] Invest Dennatol1 02: 13 -16, 1994 cells [1 6-19] . The diagnosis is based on tbe finding of keratin filament aggregates in these ce lls. However, analysis of amniotic cells is not considered rel iable enough to exclude the possibility of a false-negative diagnosis and ultrastructural analysis of fetal skin biopsies requires th e samplin g of more than one site, because tonofilament clumping may not be uniformly presented throughout the fetal epidermis [20] . Although in the no rmal fe tus keratinization does not begin until the twenty-fourth week, the sugrabasa l keratins Kl and KI0 are expressed as earl y as week 14 [21] , giving this ges tational age as the absolute lower limit for a diagnosis based on ultrastructure analysis. However, the earliest gestational age reported for a prenatal diagnosis of EHK is 19 weeks [20] . Here we report the prenatal diagnosis of twin fetuses at risk for EHK using direct gene sequencing of chorionic villus samples at 15 weeks gestation. In addition, the genetic defect causing EHK in this fami ly is described.
MATERIALS AND METHODS
Extraction of Nucleic Acids D NA was extracted from 10 ml of whole blood by lysin g cellmembrancs in an equal vo lume of 10 mM Tris-HC I (pH 7.5),0.32 M sucrose,S 111M MgCl 2 and 1 % Triton XlOO. Intact nuclei were co ll ected by centrifugation and suspended in 1.5 ml 0.9% N aCI and 1.5 ml lysis buffer (Applied Biosystems, Foster City, CAl, and incubated with proteinase K at a fin al co ncentration 0[250 Ilg/ml at 37"C for 16 h. DNA was extracted from chorionic villus sampl es by incubating approximately 20 mg of tissue in 200 III lys is buffer (10 mM Tris-HCI, pH 8.0, 2 rnM ethylenediaminte traacetic acid, 10 rnM NaCI, 5% sod iumdodecyl su lfate) and proteinase K toa linal concentration of250)1g/ml at 55 · C for 16 h. All DNAs were purified using phenol/chloroform extraction and isopropanol precipitation [22] . The extracted DNA was dissolved in 10 111M Tris (pH 7.4), 1 111M ethylened iamine tetraacetic ac id and stored at 4 · C. Concentration and purity were assessed by spectrophotometer.
peR and Nucleotide Sequencing T he l A reg ion ofKI0 was amplified from genomic DNA usin g specifi c oli gonucl eotides (5'-GAGGA-GATGGTGGCCTTCTCTCTGG-3' and 5'-GCATAGTGAACAGC-CACATTGTGC-3') co rresponding to bp 2080-2 104 and to 2372-2395 of the published sequence [23] . The 5' oligonucleo tide was biotinylated to enable the purification of single stranded DNA for seq uencing [24) . The sequencing primer used was 5'-GTATTTGCTGTAGTCACG-3', corresponding to bp 2253-2270 of the published sequence [23) . The si multa-0022-202X/94/S06.00 Copyright © 1994 by The Society for Investigative Dermatology, Inc. neous amplification and sequencing of both the mutant and wild-type alleles enables the rapid identification of nucleotide changes in affected individuals. After peR amplification, the DNA was captured onto streptavidin-coated magnetic beads via the biotinylated primer and denatured, and the resultant single-stranded DNA was used as a template in a manual DNA sequencing reaction (11) .
RESULTS AND DISCUSSION
The proband, a 32-year-old man with EHK, first approached us for a prenatal diagnosis during the thirteenth week of his wife's second pregnancy. The proband was born to unaffected non-consanguineous parents and is the only member of his family w ith a dermatologic disorder (Fig 1) . Diagnosis ofEHK was made at birth and later confirmed by ultrastructural analysis.
By history, he suffered from extensive blistering as a neonate and development of erosions and inflammation with bacterial superinfection later as a child. Episodes of blistering gradually diminished with age but were replaced with widespread hyperkeratosis. He has responded well to retinoid treatment (etretinate 35 mg daily, orally) with a diminution of hyperkeratosis. External therapy consisted of 10% urea pura ointment. The couple has had one previous pregnancy resulting in a healthy unaffected boy, now 6 years old (individual IlI.1 in Fig 1) .
To provide a prenatal diagnosis, we first had to ascertain the genetic defect of the father. of the EHK patients that we have studied to date (total of12 probands) ( [11, 14] and unpublished data), nearly 50% bear mutations within the "helix initiation" motif of KI0, a further 25% bear mutations elsewhere in the rod domain of KIO or in Kl and in the other 25% of patients we have been unable to locate a mutation within the rod domains of these keratins. It is probable that these patients harbor mutations in one of the other suprabasal keratins such as K2e [25] . In our initial analysis we sequenced the regions in which all mutations causal for EHK have been documented including the Hl, lA, and 2B segments ofKl and the lA and 2B segments of both K1 and K10 from the proband. This analysis revealed a T to A transversion, resulting in a tyrosine (Y) to asparagine (N) substitution at position 14 of the K10 1A segment (Fig 2) . No other substitutions were observed in either Kl or KIO. To ensure that this mutation was not the result of a spurious alteration introduced by the polymerase chain reaction, each reaction was repeated and the products sequenced independently. Unaffected family members did not exhibit this base change in their DNA (Fig 3) . Moreover, we have observed no sequence polymorphisms at this site in the DNA from 50 unrelated individuals, nor are there any reports of polymorphic variations of this residue in the literature.
The first 15 residues of the 1A segment are highly conserved among all intermediate filament types [26] and are thought to be involved in filament assembly through interactions with the TYRXLLEGE motif at the end of the 2B segment of neighboring molecules [27] . The tyrosine to asparagine substitution at position 14 of this highly conserved region is therefore likely to affect the Fig 1) . Normal, sequence obtained from an unaffected individual. Hetero, sequence obtained from the proband who is heterozygous for the mutant allele. The amino acid residues are numbered with respect to the beginning of the rod domain (11) . The proband bears a T-A transversion that results in a tyrosine (Y) to asparagine (N) substitution at residue 14 of the rod doman. This position corresponds to residue 160 in Rieger and Franke [23) . stability of these head-to-tail interactions, producing a weakened filament that is prone to collapse. Although there is as yet no functional data available, either from transgenic or tissue culture studies, confirming that this mutation is causal for this disease, the nature and position of the mutation suggests that it is so. This tyrosine is absolutely conserved in all human type 1 keratins sequenced to date as well as in keratins of other species and in the other intermediate filament proteins [12, 26, 28) . The high degree of conservation of this residue suggests that few, if any, changes at this position can be tolerated. Thus any mutations are likely to be deleterious and lead to disease, and on this basis we felt confident to proceed with the prenatal diagnosis.
The chorionic villus DNA samples were subsequently analyzed and both were found to contain the same T to A transversion as the proband (Fig 3) and a diagnosis ofEHK was made. We were fortunate that the proband's mutation occurred within a highly conserved and well-characterized region of the gene. Had the proband's mutation occurred in a less-conserved region we would have been very circumspect in rendering a diagnosis in the absence of supporting functional data from in "itro and transgenic studies. As our data base increases for both mutations segregating with the disease, as well as polymorphic variation within the unaffected population, these determinations will be made with greater confidence. Although this is the first report of this substitution in K10 or in any other type 1 keratin, a tyrosine-to-aspartate substitution has been described at this position in another EHK proband. The autosomal dominant mode of inheritance of EHK, coupled with its virtually complete penetrance [14] , permits prenatal diagnosis once the exact defect has been identified in th e affected patent. In this case chorionic villus samples were analyzed at 15 weeks but the technique would work equally as well at a gestational age as early as 8 weeks. Furthermore, the direct gene sequencing protocol can be used to screen ill vitro fertilized embryos, from affected couples, prior to implantation [29] . Once screened, unaffected embryos can be selected for transfer to the uterus, thereby eliminating the need for risky surgical procedures for prenatal diagnosis later in the pregnancy or for the need to terminate an affected fetus.
Note Added ill Proof
The prenatal diagnosis of EHK has since been confirmed by ultrastructural analysis of epidermal biopsies taken at 18 weeks gestational age (Dr. M. Megahed, Department of Dermatology, University of Dusseldorf, personal communication).
